Immunogenicity and the Patient: The Future is Yours
The 4th Coral Gables Symposium
Biltmore Hotel, Miami, FL
October 5-7, 2016
This years´ Coral Gables Symposia will provide a unique forum for thought leaders to address the principal concerns regarding immunogenicity and the patient. In particular, how an understanding of the immune response to biopharmaceuticals can benefit the patient both in terms of optimizing therapy, mitigating side effects, and improving outcome.
Sponsored by:
Scientific Organizing Committee
Dr. Michael Tovey, INSERM, Chair Dr. Shalini Gupta, Amgen Dr. Susan Kirshner, FDA Dr. Sebastian Spindeldreher, Novartis Dr. Robin Thorpe, NIBSC Download the Scientific Program
